112 related articles for article (PubMed ID: 1383210)
1. Apolipoprotein AI expression and high density lipoprotein distribution in transgenic mice during development.
Golder-Novoselsky E; Forte TM; Nichols AV; Rubin EM
J Biol Chem; 1992 Oct; 267(29):20787-90. PubMed ID: 1383210
[TBL] [Abstract][Full Text] [Related]
2. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
Rubin EM; Ishida BY; Clift SM; Krauss RM
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299
[TBL] [Abstract][Full Text] [Related]
3. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
4. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
Li H; Gu S; She M
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
[TBL] [Abstract][Full Text] [Related]
5. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
Holvoet P; Danloy S; Collen D
Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
[TBL] [Abstract][Full Text] [Related]
6. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
Srivastava RA
Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
[TBL] [Abstract][Full Text] [Related]
8. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
[TBL] [Abstract][Full Text] [Related]
9. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
Srivastava RA; Baumann D; Schonfeld G
Eur J Biochem; 1993 Sep; 216(2):527-38. PubMed ID: 8375391
[TBL] [Abstract][Full Text] [Related]
10. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism.
Srivastava RA
Biochem Mol Biol Int; 1994 Sep; 34(2):393-402. PubMed ID: 7849650
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
Srivastava RA; Krul ES; Lin RC; Schonfeld G
Mol Cell Biochem; 1997 Aug; 173(1-2):161-8. PubMed ID: 9278267
[TBL] [Abstract][Full Text] [Related]
12. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.
Major AS; Dove DE; Ishiguro H; Su YR; Brown AM; Liu L; Carter KJ; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1790-5. PubMed ID: 11701467
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice.
Srivastava RA; He S; Newton RS
Biochim Biophys Acta; 2011 Feb; 1811(2):76-83. PubMed ID: 21081177
[TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.
Lagrost L; Perségol L; Lallemant C; Gambert P
J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353
[TBL] [Abstract][Full Text] [Related]
16. Structure and stability of apolipoprotein J-containing high-density lipoproteins.
Stuart WD; Krol B; Jenkins SH; Harmony JA
Biochemistry; 1992 Sep; 31(36):8552-9. PubMed ID: 1390641
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
[TBL] [Abstract][Full Text] [Related]
18. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.
Gao J; Wei Y; Huang Y; Liu D; Liu G; Wu M; Wu L; Zhang Q; Zhang Z; Zhang R; Liang C
J Biol Chem; 2005 Apr; 280(13):12559-66. PubMed ID: 15649902
[TBL] [Abstract][Full Text] [Related]
19. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
20. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
Han Y; Qi R; Liu G
Biochem Biophys Res Commun; 2015 Jul; 462(4):420-5. PubMed ID: 25969427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
